Cure Alzheimer's Fund Cure Alzheimer's Fund

Hermann Steller, Ph.D.

Strang Professor; Head of the Laboratory of Apoptosis and Cancer Biology, The Rockefeller University

Dr. Hermann Steller Ph.D. is the Strang Professor and Head of the Laboratory of Apoptosis and Cancer Biology at the Rockefeller University and an investigator of the Howard Hughes Medical Institute. Prior to this, he was professor of neurobiology at the Massachusetts Institute of Technology in Cambridge, Massachusetts. Dr. Steller has served on many advisory boards and committees, including as chairman of the CDF-5 study section at the National Institute of Health, and he is currently the chair of the Academic Council of the Rockefeller University. Dr. Steller pioneered the use of Drosophila as a genetic model for cell death research, and this work has provided many important new insights into the regulation of apoptosis. Dr. Steller received his diploma in microbiology and molecular genetics from the University of Frankfurt, and his Ph.D. in molecular biology from the European Molecular Biology Laboratory and the University of Heidelberg. He is a member of the National Institutes of Health, American College of Surgeons and is an assistant neurobiologist at Massachusetts General Hospital in Boston

Related Research:

Stimulating Synaptic Proteasome Activity for the Treatment of Alzheimer’s Disease Hermann Steller 2022-02-15 Stimulating Proteasome Activity for the Treatment of Alzheimer’s Disease (Year 1) Hermann Steller 2018-08-09

Funded Research

These projects were made possible from Cure Alzheimer's Fund support.

Project Description Researchers Funding
Stimulating Synaptic Proteasome Activity for the Treatment of Alzheimer’s Disease 2021, 2022

$345,000
Stimulating Proteasome Activity for the Treatment of Alzheimer’s Disease (Year 1) 2017, 2019

$300,000

Selected Publications

These published papers resulted from Cure Alzheimer’s Fund support.

Rodriguez, J. A., Minis, A., Aref, R., Nguyen, H. H. M., Sun, F., & Steller, H. PI31 expression is neuroprotective in a mouse model of early-onset parkinsonism, Proceedings of the National Academy of Sciences of the United States of America, September 16, 2025, Read More

Minis, A., Rodriguez, J. A., Levin, A., Liu, K., Govek, E. E., Hatten, M. E., & Steller, H. The proteasome regulator PI31 is required for protein homeostasis, synapse maintenance, and neuronal survival in mice, Proceedings of the National Academy of Sciences of the United States of America, November 21, 2019, Read More

Back to Our Researchers